1. Home
  2. ACNT vs MSLE Comparison

ACNT vs MSLE Comparison

Compare ACNT & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Industries Co.

ACNT

Ascent Industries Co.

HOLD

Current Price

$13.54

Market Cap

133.2M

Sector

Industrials

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$6.07

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ACNT
MSLE
Founded
1945
N/A
Country
United States
Canada
Employees
N/A
17
Industry
Steel/Iron Ore
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
133.2M
146.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ACNT
MSLE
Price
$13.54
$6.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
64.4K
27.7K
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
106.72
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.62
$5.50
52 Week High
$17.92
$13.39

Technical Indicators

Market Signals
Indicator
ACNT
MSLE
Relative Strength Index (RSI) 43.07 36.99
Support Level $11.95 $5.50
Resistance Level $16.80 $8.59
Average True Range (ATR) 0.49 0.44
MACD -0.07 -0.06
Stochastic Oscillator 26.08 1.24

Price Performance

Historical Comparison
ACNT
MSLE

About ACNT Ascent Industries Co.

Ascent Industries Co is a specialty chemicals company focused on the development, production, and distribution of tailored, performance-driven chemical solutions. Its customers are spread across energy, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), agriculture, water treatment, pulp and paper, construction, automotive, and other industrial markets. The company's core product portfolio includes surfactants, defoamers, lubricating agents, flame retardants, and specialty intermediates, offered in both petroleum-based and bio-based formulations. Geographically, it generates maximum revenue from the United States, followed by Mexico, Canada, Honduras, Colombia, the Netherlands, Costa Rica, Japan, and other markets.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: